Drug Trial Radar · NCT00576368
An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice
Last checked: Nov 20, 2026Latest source record: Jan 9, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,464
Actual
Start
Jun 2003
Primary completion
Not stated
Study completion Apr 2004
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Dec 19, 2007
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this survey on this registered product is to confirm the efficacy, and safety profile of Lantus in every day medical practice. This program will also help to obtain information about the use of the insulin titration regimen and handling of the Lantus insulin analogue.
Conditions
- Diabetes Mellitus
Interventions
INSULIN GLARGINEDrug
The physician will be guided by the prescribing information outlined in the summary of product characteristics. The administration will be done by once daily subcutaneous injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Glycemic status (Fasting Blood Glucose, Fasting Plasma Glucose, and HbA1C as done in routine medical practice)Time frame: at least 3months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sanofi-Aventis
Brussels, Belgium
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.